TKThomas Kuete

Thomas Kuete

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Kuete has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence, Associated Factors and Treatment Outcomes of Laboratory-confirmed Pregnancy Malaria at Antenatal Care in Three Healthcare Facilities of Douala, Cameroon

    by Thomas Kuete, Henri Essome, Larissa Boukam Moche, Nadège Anabianina, Christiane Keddy Mangamba, Albert Same Ekobo

    Pregnancy malaria is a life-threatening condition to the mother, the fetus and the newborn. Since the implementation of the World Health Organization’s recommendations of specific malaria control strategies to pregnant women in malaria endemic countries, evaluation studies are needed to assess the prevalence of malaria in pregnancy. This cross-sectional prospective study was therefore set to determine the prevalence and associated factors as well as the treatment outcomes of Plasmodium infection among pregnant women attending antenatal care in three hospitals of Douala in Cameroon. Each volunteered pregnant woman received for antenatal care was questioned according to the study questionnaire to collect sociodemographic data, use of malaria prevention tools and pregnancy history. Then a laboratory test was carried for Plasmodium detection in the peripheral blood using microscopy and a HRP2-based rapid diagnostic test. Plasmodium carrying pregnant women were treated according to the national malaria program scheme followed by post-treatment follow-up. Data were processed and analyzed using SPSS.20 software. Association of Plasmodium infection with risk factors was analyzed as univariate using Pearson Chi-square and Fisher Exact tests considering a P-value < 0.05 as statistically significant. A total of 487 pregnant women aged between 18 years and 42 years were included in the study. The prevalence of Plasmodium infection was 3.5% and 4.3% by malaria rapid diagnostic test and microscopy respectively. Only Plasmodium falciparum asexual stage was detected. Parasite loads were low. Factors associated with Plasmodium falciparum higher prevalence were being less than 21 years old (0.02), not sleeping under mosquitoe net daily (p=0.04) and having fever during the pregnancy (p=0.04). Parenteral treatment with either artesunate, artemether or quinine sulfate showed good efficacy. Conclusion: Pregnant women attending the antenatal cares harbored low Plasmodium infection prevalence and loads. Being of young age, not sleeping under mosquitoe bednet daily and having fever during the pregnancy were predictive Plasmodium falciparum. Plasmodium infected pregnant women were successfully treated with antimalarial medications recommended by the national Ministry of Public Health. The authors recommend increasing efforts by health authorities to strengthen malaria prevention in pregnant women through more adherence to sleeping under ITNs daily and taking IPT-sp as well as systematic detection of Plasmodium infection at each antenatal visit.


  • Open Access

    Influence of the Incubation Time on the Inhibition in the Aquatic Microcosm of Some Bacteria of Health Importance by Synthesized O-Propargyl vanillinic Chalcones

    by Luciane Marlyse Moungang, Christophe Colombe Simo Fotso, Pantaleon Ambassa, Thomas Wieland Moifo Kuete, Idriss Tchoupou Tchoffo, Raphael Balock Um, Aurelie Dzenga Djeunkam, Xavier Siwe-Noundou, Charles Fokunang, Moïse Nola, et al.

    Background: The germs of waterborne diseases are often associated with an increase in resistance, which contrasts with the discovery of new active molecules, thus complicating treatment. Research is therefore undertaken to discover new substances with therapeutic potential. Although plants are an important source for obtaining interesting compounds, methods based on synthetic chemistry make it possible to obtain compounds inspired by those found in nature and presenting equally important properties. One group of these compounds, called chalcone, is of great importance nowadays due to the diversity of biological activities it presents; therefore, many chalcone derivatives are synthesized and their biological activities evaluated. Methodology: The compounds were synthesized by Claisen-Schmidt condensation in a basic medium (potash 5%). The reaction was followed by thin layer chromatography. At the end of the reaction, filtration after cooling of the reaction medium allowed the collection of part of the product that precipitated, while liquid-liquid extraction (water-acetate) allowed to obtain the rest still dissolved. The products obtained were purified by column chromatography using the Hexane/Ethyl Acetate system. The characterization of the products was carried out on the physical properties and also the nuclear magnetic resonances of the proton and carbon 13. The use of isolation media for each of the 04 bacteria studied, namely ENDO, SS, TCBS and BEA agars, permitted the isolation of Escherichia coli, Salmonella typhi, Vibrio cholerae and Streptococcus feacalis, respectively. The microbiological technique for counting bacterial colonies in solid medium, as well as the microdilution in liquid medium allowed the evaluation of the action of the different chalcones. Results: Four O-propargyl vanillinic chalcones 5a-5d were obtained by Claisen Schmidt condensation method with respective yields of 63.6%; 66.7%; 66.7% and 70.0%. The evaluation of their antibacterial activities was done on four strains of bacteria including E. coli, S. typhi, V. cholerae and S. feacalis isolated from wells in the city of Yaoundé. Statistical data from the results of the solid-state bacterial colony counting technique revealed a lack of significance (p > 0.05) with respect to the variation of the mean bacterial abundance as a function of the concentrations of each chalcone (except that of the S. feacalis with respect to compound 5b). The results of the microdilution test showed the lowest MIC values with compound 5d (250 µg/mL), against S. typhi. Chalcones 5c and 5d exhibited better activity on E. coli (MIC value of 500 µg/mL) compared to the reference antibiotic: ampicillin (MIC > 1000 µg/mL). Chalcones 5a and 5b were the least active on all bacteria studied, with MIC values greater than or equal to 1000. Conclusions: The microdilution tests showed an antibacterial activity of the synthesized compounds, with a better activity for the chalcone 5d.

  • Open Access

    Multicentre study evaluating the non-inferiority of the new paediatric formulation of artesunate/amodiaquine versus artemether/lumefantrine for the management of uncomplicated Plasmodium falciparum malaria in children in Cameroon, Ivory Coast and Senegal

    by Babacar Faye, Thomas Kuété, Christiane P Kiki-Barro, Roger C Tine, Thérèse Nkoa, Jean Louis A Ndiaye, Claude A Kakpo, Khadime Sylla, Hervé Ei Menan, Oumar Gaye, et al.

    This multicentre study was carried out in Cameroon, Ivory Coast and Senegal to evaluate the non-inferiority of the new paediatric formulation of artesunate/amodiaquine (AS+AQ)(Camoquin-Plus Paediatric®) in suspension form versus artemether/lumefantrine (AL)(Coartem®) in the management of African children with uncomplicated falciparum malaria.


  • Open Access

    Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa

    by William Yavo, Babacar Faye, Thomas Kuete, Vincent Djohan, Serge A Oga, Richard R Kassi, Mariama Diatta, Moor V Ama, Roger Tine, Jean-Louis Ndiaye, et al.

    The choice of appropriate artemisinin-based combination therapy depends on several factors (cost, efficacy, safety, reinfection rate and simplicity of administration). To assess whether the combination dihydroartemisinin-piperaquine (DP) could be an alternative to artemether-lumefantrine (AL), the efficacy and the tolerability of the two products for the treatment of uncomplicated falciparum malaria in sub-Saharan Africa have been compared.


  • Open Access

    Comparative study of the efficacy and tolerability of dihydroartemisinin - piperaquine - trimethoprim versus artemether - lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroon, Ivory Coast and Senegal

    by Hervé Menan, Oumar Faye, Albert Same-Ekobo, Agbaya Serge S Oga, Babacar Faye, Christiane P Kiki Barro, Thomas Kuete, Jean-Louis N'Diaye, Ama-Moor Vicky, Rogert Tine, et al.

    The ACT recommended by WHO is very effective and well-tolerated. However, these combinations need to be administered for three days, which may limit adherence to treatment.


  • Open Access

    Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria

    by Jean Louis A Ndiaye, Babacar Faye, Amadou M Diouf, Thomas Kuété, Moustapha Cisse, Papa A Seck, Phillipe Brasseur, Albert Same-Ekobo, Valerie Lameyre, Oumar Gaye

    Artesunate plus amodiaquine is a coblistered ACT, given as a single daily intake. It has been suggested that, in view of the number of tablets to be taken (particularly in adults), it may be possible to improve compliance by allowing patients to divide the daily dose. The objectives of this randomized, comparative, open-label, multicentre study, conducted in Senegal and in Cameroon in 2005, was to demonstrate the non-inferiority and to compare the safety of artesunate plus amodiaquine, as a single daily intake versus two daily intakes.